SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE)-- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Future/Leon ...

Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. We’re giving this sale our kiss of approval. Made with ...

On February 12, 2026, Outset Medical, Inc. (NASDAQ:OM) shares received fresh support from analysts despite a decline in price targets after fourth-quarter results that largely met expectations. After ...

Leslie Trigg, President, CEO & Chairman, opened by stating that “while we've made significant progress transforming our sales process and strengthening our team, our third quarter results show that ...

The FDA cleared Outset's Tablo dialysis device for home use. Home dialysis presents an $8.9 billion annual market opportunity for Outset. Reimbursement changes should help boost use of Tablo in home ...